We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Postmarket Studies for Breast Cancer Drugs Treating Premenopausal Women
FDA Seeks Postmarket Studies for Breast Cancer Drugs Treating Premenopausal Women
Sponsors developing drugs to treat breast cancer should consider including premenopausal women in their clinical trials and may be required to conduct postmarketing studies to analyze the long-term effects of these treatments, the FDA said in a final guidance.